NEW YORK (GenomeWeb) – Roche today said that it has signed a definitive agreement to acquire Flatiron Health, a maker of oncology-focused electronic health records.

Roche already held a nearly 13 percent stake in the New York City-based firm through an earlier investment. It said that it will pay $1.9 billion to Flatiron Health to close the deal, which is expected to occur in the first half of this year.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.